Maternity services at Chesterfield Royal Hospital NHS Foundation Trust have received a Care Quality Commission (CQC) rating of ‘good’, following an inspection of their safety and leadership in May.
The trust achieved the ‘good’ rating for their maternity services overall, a score they have maintained since their last inspection in May 2020.
CQC inspectors noted that leaders “ran services well” with “reliable information systems”, and were seen to monitor effectiveness of the service with focus on ensuring that staff were competent; that they understood the service’s visions and valued; and they were supported to develop their skills.
The culture of the service in particular received praise, with chief nurse Krishna Kallianpur commenting: ““I am particularly pleased that the CQC recognised and highlighted such a positive culture where colleagues feel respected, supported and valued. It’s important to all of us across the trust to be able to raise concerns without fear and this, too, was raised as a positive with leaders being visible and approachable.”
Krishna added: “Our goal is for continuous improvement and development, so working with organisations such as Derbyshire Maternity and Neonatal Voices Partnership and directly with our communities, I feel we can continue to learn and develop and continue to strive as well as celebrate this achievement together.”
In addition, inspectors noted that safety incidents “were managed well and lessons learned from them”, with the service acting on risk assessments and keeping good care records.
We recently explored a range of CQC rating updates from healthcare organisations in the West Midlands, London, Warwickshire and Gloucestershire; click here to find out more.
In addition, we also covered the CQC’s plans to pilot their new assessment process at Birmingham and Solihull ICS along with Dorset ICS, which will see a new framework assessment focusing on gathering evidence in six key areas, including people’s experiences of services, staff and leader feedback, and feedback from partners. The new process sits alongside a review of data and evidence across all 42 ICSs; read more here.
